Interview: Andrew Eve – General Manager and Head of Prescription Medicine, Boehringer Ingelheim, South Africa
11.11.2015
Related Interviews
Interview: Charl De Klerk – General Manager, Bard South Africa
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
Interview: Albert Denoon – Owner, Baroque Medical, – Board Member,…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
Interview: Andre Buhrlen – Managing Director, Hersol Manufacturing…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Australia / Artificial Intelligence Can Save Pharmacovigilance
Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health, Melbourne and St. Vincent’s Hospital Sydney outline how…
China / Emerging Pharmacovigilance Framework Ensuring Safe COVID-19 Vaccines
PPC China’s Sophia Duan, writing in the January edition of DIA’s Global Forum magazine, details how the emergence of an effective pharmacovigilance ecosystem is helping to safeguard the rollout of…
Spain / 5 Key Industry Trends 2021
According to recent IQVIA and industry association reports, the Spanish pharma market, valued at EUR 21.6 billion per year, continues to grow at a relatively slow pace. Other key trends…
Latest Report
